Shandong Baofa Research Institute

Shandong Baofa Cancer Institute is a specialized oncology research and clinical organization based in Jinan, China, founded by the prominent oncologist Dr. Baofa Yu. The institute is renowned for developing the UMIPIC (Ultra-minimum Incision Personalized Intratumoral Chemotherapy) platform, which combines local drug delivery with immunotherapy. This proprietary technology involves the direct injection of chemotherapy agents and haptens into solid tumors to induce a systemic anti-tumor immune response, effectively creating an in vivo autologous vaccine. The institute operates a network of specialized cancer hospitals and research centers that focus on treating advanced-stage malignancies, including pancreatic, lung, and liver cancers. Its innovative approach aims to provide effective treatment options for patients who have exhausted conventional therapies while minimizing the toxic side effects associated with systemic chemotherapy.